Background: The relative contribution of psychological factors to the onset and course of inflammatory bowel diseases (IBD) is a matter of constant
I
nflammatory bowel diseases (IBD), Crohn's disease (CD), and ulcerative colitis (UC) affect about 400,000 patients in Germany, with a lifetime prevalence up to 1% in Western industrial countries. 1, 2 In both entities, genetic-driven perturbances of the intestinal barrier and therefore the contact with millions of gut bacteria is in the center stage of the disease. 3, 4 However, it is a common fact that IBD is shaped by genetic and environmental conditions. Environmental influence means not only microbes, chemicals, or food. In a biopsychosocial disease perspective, 5 chronic diseases such as IBD are characterized by influences through psychological harms such as anxiety or depression and social interrelations influenced by disease activity, even though only a few data are available for a biopsychosocial disease perspective in IBD. [6] [7] [8] Nevertheless, the relative contribution of psychological factors to onset 9 and/or course 6 of IBD is a matter of constant debate since its beginning, 10, 11 whereas their exact contributions to disease etiology and pathomechanisms are yet unclear. 11, 12 Clear evidence is available, that anxiety, mood disorders (e.g., major depression), and poor quality of life, have a high prevalence in patients with IBD as found in large patient cohorts in the USA and in Europe. 9, 13 Among others, psychosocial stress (daily hassles and major life events), depression, and anxiety have been named as contributing factors to the disease progression by means of triggers of flares, 6, [14] [15] [16] [17] but data have remained inconclusive, because negative associations have also been reported. 18, 19 Therefore, both psychotherapy (PT) or psychotropic drug (e.g., antidepressant drug treatment) interventions during the acute phase of the disease or during remission have produced supportive 17, [20] [21] [22] [23] and contradictory evidence in terms of influence on the disease activity. [24] [25] [26] In whole, evidence base seems weak or inconclusive, 27 underlined by a recent systematic review by Fiest et al identifying not a single controlled clinical treatment trial for depression and anxiety in patients with IBD. 28 Most frequently, supportive PT interventions in clinical management were conducted as randomized controlled trials in tertiary centers, comparing treatment as usual (or another medicinal equivalent, e.g., a novel drug) with an additional psychotherapeutic intervention of variable kind and intensity. 22 This does not reflect, however, that many patients with CD or UC may seek PT support independent of randomized controlled trial, under primary and secondary care physician supervision, or self-selected and independent of their actual medical monitoring, but data regarding these facts are sparse or even not available to the best of our knowledge.
The assumption that patients with IBD may organize PT on their own is strengthened by the fact that about 75% to 90% of patients believe that stress or personality influences the onset and the course of their disease. 29, 30 However, only about 20% of patients with anxiety and/or depressive symptoms receive additional psychological treatment as shown in a Dutch patient cohort. 31 Therefore, participation in randomized controlled trials may not reflect the true PT experience in patients with IBD, as is well known for medical therapy, 32 nor may it reflect the PT demand, dependent or independent of previous experiences. The latter has, to the best of our knowledge, never been assessed in a reasonably sized IBD-patient survey.
We therefore set out to explore the PT experience and demand of unselected (or self-selected) patients with either CD or UC, independent of their current disease management (primary, secondary, and tertiary), using a web-based questionnaire, advertised by and distributed to as many patients as possible by the help of the "Deutsche Morbus Crohn und Colitis ulcerosa Vereinigung e.V." (DCCV e.V.) (www.dccv.de), member of the European Federation of Crohn's, and Ulcerative Colitis Associations (EFCCA), the umbrella organization of all 26 national IBD patient organizations in Europe (www.efcca.org).
METHODS
Between December 2014 and January 2016, a questionnaire and test battery were placed on the webpage of our institution (http://www.med.uni-tuebingen.de/Presse_Aktuell/Einrichtungen +A+bis+Z/Kliniken/Medizinische+Klinik/Innere+Medizin+I.html), which was freely accessible to all interested patients. Furthermore, the questionnaire was announced on the website of the DCCV (www.dccv.de) and mentioned in newsletters sent to all (n ¼ 20,667) DCCV members. Patients with IBD seen at our hospital were also asked to complete the online survey. The survey had been submitted to the Ethics Board of the University Medical School of Tübingen for a review and approval that was granted by decision on November 12, 2014. By answering the questions, patients gave implicit consent; however, no personalized data were collected that would allow identification of a patient's identity.
Questionnaire and Tests

Questionnaire for General Background
The questionnaire comprised questions related to the disease history (diagnosis, disease duration, intestinal and extraintestinal manifestations, previous inpatient/outpatient treatments including surgery and PT), social data (age, sex, and family status), and health behaviors (smoking and DCCV membership).
SIBDQ
The Short Inflammatory Bowel Disease Questionnaire (SIBDQ) is a 10-item questionnaire (all rated between 0 and 7, with shifted polarity) [33] [34] [35] that has been validated against other quality-of-life measures (SF36, HADS) and against its original version, the IBDQ. 36 The validated German version is available since 2000. 37 
ADAPT
The Assessment of the Demand for Additional Psychological Treatment (ADAPT) is a 12-item (each question answered on a 10 cm visual analog scale ranging from 0 points "no, not at all" to 100 points "yes, completely right") questionnaire, developed originally in German language. 38 ADAPT was designed to assess the demand for 3 different dimensions of psychological support independently: the need for disease-oriented counseling, integrated psychosomatic care, and PT. 38 Disease-oriented counseling is defined as comprehensive talks focused on the disease and on disease-related items in a sufficient time frame, which can be carried out by any physician with knowledge in the field of IBD. Integrated psychosomatic care means intermittent psychological interventions focusing on biopsychosocial interactions of IBD. PT is defined as extensive and planned treatment of emotional suffering by psychotherapeutic methods performed by a psychotherapist rather than a gastroenterologist. [38] [39] [40] A summarized total score of 65 points and above (sum of disease-oriented counseling, integrated psychosomatic care, and PT subscores) indicate increased demand for psychological support in whole, as screening test for the need of any of the above-mentioned subcategories. [38] [39] [40] The ADAPT has been applied to patients with IBD, [38] [39] [40] but also to patients with other chronic conditions such as interferon-induced depression in hepatitis C. 41 However, a major limitation is that the test assesses the current psychological condition of a patient rather than a stable "psychological value," therefore, the test results can change during different life periods. Nevertheless, the ADAPT score is simple, short, easy to understand and to answer, and delivers scores easy to use in daily clinical care.
FoP-Q-SF
The Fear of Progression Questionnaire Short Form (FoP-Q-SF) (German: Progredienzangst Fragebogen Kurzform, PA-F-KF) 42 rates 12 items between 0 ¼ (never) and 4 ¼ (very often) (5-point Likert-scale) that are added for a total score. The items are grouped into 5 subscales with questions regarding affective reactions (e.g., "I'm afraid of pain."), partner/family (e.g., "I'm afraid that my children will suffer from the same disease."), work (e.g., "Thoughts of not functioning at work make me trouble."), loss of autonomy, and coping with fears. Therefore, this score includes different aspects of anxiety in daily life affected by chronic diseases, but as a limitation this score is not designed to screen for anxiety disorders. Fear of progression has been studied in cancer and other chronically ill patients using the Fear of Progression Questionnaire (FoP-Q; long form); patients, e.g., with rheumatoid arthritis were found to have high values. 43 To the best of our knowledge, this test has not been applied to patients with IBD so far.
Statistics
Data were screened for completeness of answers, and only complete data sets were included. Patients were subdivided according to their answers to the following questions: "Did you ever had PT in the past" (yes, no) and the ADAPT score with a cutoff of 65 points (yes and no). This 2 · 2 matrix was then tested for intercorrelation of demand · experience by Chi-square test. Furthermore, qualitative data were tested between groups by Chi-square tests, and numeric data and psychometric test scores were entered into a 2 · 2 ANOVA. Relevant data (that were identified in the previous analyses) were then entered into a multiple regression analysis with ordinal and nominal variables (age, sex, smoking, diagnosis [CD, UC], duration of disease, DCCV membership, frequency of previous inpatient treatments, any previous surgery, and extraintestinal manifestations) as variables to be used in a stepwise forward manner. Regression was analyzed for "psychotherapy demand" (ADAPT score) using the FoP-Q-SF score and the SIBDQ score as additional potential predictors. A stepwise forward inclusion was used to find the model with maximum R 2 that has the highest explanation potential for all patients with IBD together. The analysis was repeated for patients with UC and CD separately. All statistics were performed using SPSS Version 19. All data are reported as mean 6 SD, and the alpha level indicating statistical significance was set at , 0.05.
RESULTS
Study Population
A total of 631 individuals answered the questionnaire within 14 months. After exclusion of incomplete data sets, 578 (356 patients with CD, 219 with UC, and 3 remaining cases unclear) data sets remained and were entered into the analyses. The mean age of the cohort was 36.65 years (611.15). Seventy five percent of the participants were female, 25% male. Disease duration was between ½ and 2 years in 6%, between 2 and 10 years in 44% of the patients, and .10 years in 50% of the participants.
Psychotherapy Experience and Demand for It in Patients With IBD
To answer our key research question, we first analyzed the data regarding patients demand for PT, defined as an ADAPT score .65 points. A total of n ¼ 271 (47%) patients exert a demand for PT, whereas n ¼ 307 (53%) does not want additional PT as measured by the ADAPT score (Table 1) . Furthermore, we were interested, whether the patients in our cohort had any previous experience with PT. A total of n ¼ 296 (51%) patients already experienced PT, whereas n ¼ 282 (49%) did not (Table 1) . Patients with PT experience have a higher demand for PT compared with patients without previous PT, as shown by the significantly affected ADAPT total score by PT experience (P , 0.001) ( Table 1 ). In addition, younger patients have a tendency toward a higher demand for PT (P ¼ 0.054), whereas older patients with IBD are more likely to have a history of PT (P ¼ 0.03) ( Table 1) .
Most interestingly patients with a history of stoma (previous or current) have a significant higher rate of previous PT (P ¼ 0.004), but this has no influence on the current demand for PT. In line with this, a higher number of IBD-related surgeries is negatively associated with a demand for PT (P , 0.001) and positively related to previous PT (P , 0.001).
Analyzing some health-behavior-related issues regarding PT experience and demand we found that DCCV (patient organization) membership is associated with a significant higher rate of previous PT (P , 0.002) and a higher demand for PT (P ¼ 0.031). Furthermore, nonsmoker-status is associated with a demand for PT (P , 0.001) but not with previous PT (P , 0.001) ( Table 1) .
The longer the duration of the disease (IBD in years), the higher the PT experience (P , 0.001), however, the demand for PT diminishes over the years of disease (P , 0.001). Sex, IBD entity (UC/CD), or frequency of inpatient treatments have no influence on PT demand or previous PT in our patient cohort (Table 1) .
Looking at the analysis regarding fear of progression (FoP-Q-SF score), we can see that there is a higher demand for PT in patients with higher fear of disease progression scores (P , 0.001). In addition, there is a higher demand for PT in patients with low quality of life (P , 0.001). However, high FoP-Q-SF and low SIBDQ scores are not connected to previous PT ( Table 1) .
Predictors of the Demand for PT in Patients with IBD
In the next step, we were interested in the social, clinical, and psychometric test variables predicting a demand for PT, to develop a test battery for clinical use that allows screening for patients with PT demand.
As shown in Figure 1 , multiple stepwise linear regression analysis of all studied variables demonstrated that previous experience (P , 0.001), high fear of progression (P , 0.001), low quality of life (P , 0.001), nonsmoking (P ¼ 0.016), and no previous IBD-related surgery (P ¼ 0.005) were independent predictors of demand for PT (Fig. 1) . Therefore, 5 clinical, social, or psychometric variables explain the demand for PT (ADAPT score), with the total model explaining 29.7% of the variance (Fig. 1) . Although this prediction model did not show that the type of disease (UC or CD) contributes to the explanation of dependent variables, we repeated the above regression analysis for UC and CD separately, to clarify whether the same or different prediction models exist for the 2 diseases.
Predictors of the Demand for PT in Patients with UC
Higher PT demand in UC is associated with previous PT experience (P ¼ 0.002), higher fear of disease progression FIGURE 2. Predictors of the demand for psychotherapy (ADAPT score .65): regression analysis for patients with ulcerative colitis reveals different variables predicting the demand for psychotherapy. Direction of arrows indicates "positive" (up) or "negative" (down) association of predictor with PT demand. In the case of dichotomous variables-"yes" (up ¼ presence of a factor) or "no" (down ¼ absence of a factor) increases PT demand. ADAPT, assessment of the demand for additional psychological treatment; PT, psychotherapy. FIGURE 1. Predictors of the demand for psychotherapy (ADAPT score .65): regression analysis of all patients with IBD reveals different variables predicting the demand for psychotherapy. Direction of arrows indicates "positive" (up) or "negative" (down) association of predictor with PT demand. In the case of dichotomous variables -"yes" (up ¼ presence of a factor) or "no" (down ¼ absence of a factor) increases PT demand. ADAPT, assessment of the demand for additional psychological treatment; IBD, inflammatory bowel disease; PT, psychotherapy .
(P , 0.001), lower quality of life (QoL) (P ¼ 0.003) and nonsmoking status (P ¼ 0.018). These predicting variables together explain 37.6% data variance (Fig. 2) .
Predictors of the Demand for PT in Patients with CD
As in UC, higher PT demand in CD is associated with previous PT experience (P , 0.001), higher fear of disease progression (P ¼ 0.002) and lower QoL (P ¼ 0.006) (Fig. 3) . However, in the separate analysis for patients with CD no previous IBD-related surgery (P ¼ 0.008) is an additional predicting variable for the demand of PT, not found as predicting variable in UC. Together the 4 factors explain 25.4% data variance (Fig. 3) .
DISCUSSION
To the best of our knowledge, this is the first nationwide investigation studying the demand for PT from an IBD patient's point of view. One of the key findings is the substantive need for PT, expressed by the fact that about half of all investigated patients want additional PT, as measured by the ADPT score. Patients with higher demand for PT are younger and most interestingly higher demand is associated with previous PT experience. Therefore, one can conclude that for these patients, PT seems to be a constant therapeutic column in IBD treatment. However, also independently of previous PT, demand is also high in patients without PT experience, clearly demonstrating that PT is a subject of constant interest for a notable amount of patients with IBD.
Although it is well known that anxiety and depression have a high prevalence in patients with IBD, 9,13 comprehensive assessment of demand for PT has not been established in clinical routine so far. Nevertheless, looking at our data, physicians should be aware of this patient concern which might be common but not discussed by patients and physicians in daily routine, underlined by the fact that only a few patients with anxiety or depressions get the care they need. 31 In our total IBD patient cohort (both UC and CD), nonsmokers and patients without any history of previous surgery have a special demand for PT. One can speculate that nonsmoker state is an expression of a health-oriented way of life, suggesting that those patients also have more information regarding health and their IBD. Disease-specific knowledge is a known risk factor for anxiety in patients with IBD, as shown by Selinger et al. 44 The authors could show that better disease-specific knowledge (assessed by the "Crohn's and Colitis knowledge score"), female sex, and "Crohn's and Colitis Association" membership were associated with higher anxiety, impairing quality of life. 44 Furthermore, patients without previous surgery might have more fear for surgery than patients who had already undergone surgery, resulting in a need for disease-specific counseling, but reasons for that association remain speculative at this point (further discussion see below).
A further key finding of our study is the fact that there is a high intercorrelation between the demand of PT, quality of life (QoL), and fear of progression (FoP) themselves in patients with IBD. Patients with high FoP and low IBD-related QoL want more PT-based counseling to deal with negative disease influences. Therefore, identification of patients with IBD with a need for PT may improve QoL and reduce FoP by psychotherapeutic support. Although past studies investigating PT interventions in IBD showed inconclusive results regarding influence on the course of disease, 17, [20] [21] [22] [23] [24] [25] [26] PT to improve QoL in IBD could be a beneficial therapeutic column in IBD care, if a more personalized approach is taken.
The comparison of the regression analyses for UC and CD separately, to clarify whether the same or different models exist for the two diseases, revealed some disease-specific highlights. Regarding the ADAPT score, especially in CD, no history of surgery seems to be a factor driving the need for PT. But also performed surgery itself is a factor driving depression and anxiety in IBD at least in a time period of 5 years after surgery as shown by Ananthakrishnan et al. 45 However, this study revealed no differences between patients with CD and UC regarding the period after surgery. 45 Based on our data, we speculate that the initial need for surgery is especially a concern for patients with CD, whereas thoughts about surgery from a UC patient's point of view is associated with less concerns because of the curative intention in the case of total proctocolectomy.
There are several strengths of our study. At first we investigate a "real life" patient cohort, without selection of e.g., tertiary care patients. The large number of more than 570 patients are, to the best of our knowledge, unique regarding our scientific FIGURE 3. Predictors of the demand for psychotherapy (ADAPT score .65): regression analysis for patients with Crohn's disease reveals different variables predicting the demand for psychotherapy. Direction of arrows indicates "positive" (up) or "negative" (down) association of predictor with PT demand. In the case of dichotomous variables-"yes" (up ¼ presence of a factor) or "no" (down ¼ absence of a factor) increases PT demand. ADAPT, assessment of the demand for additional psychological treatment; IBD, inflammatory bowel disease; PT, psychotherapy.
question, and the cohort consists to equalize parts of patients with and without PT experience without a self-selection bias. Furthermore, the demand for PT could be objectively measured by the ADAPT score. On the other hand, we have to appoint some limitations, such as the assessment of only 3 psychometric tests with our questionnaire to make the survey feasible for the participants, as well as the fact that we do not have information regarding the detailed medical patient history, including no data on the timing, duration, type, and efficacy of previous PT in the past.
To summarize, in our study, about half of the patients with IBD clearly express a need for additional PT. Assessment of a few predictive variables such as age, previous surgery, previous PT, smoking habits, and maybe level of patient information combined with the ADAPT, FoP-Q-SF, and SIBDQ scores are able to identify patients with a demand for PT.
However, despite the comprehensive evaluation as done in our study and the identification of the above-mentioned predictive variables, it is still not possible to explain the whole factors driving the demand for PT in patients with IBD. Our model only predicts about a third of the patients who have a need for PT. Therefore, there have to be other factors that should be further explored in future studies.
Nevertheless, our data provide the first step allowing a rational planning of the management of patients with IBD in daily clinical routine and avoid mainstream psychotherapeutic therapy offers, leading to a "personalized medicine" approach regarding psychotherapeutic interventions in IBD to improve patient's quality of life in daily care.
